Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary vascular complications of liver disease. While HPS is characterized by low pulmonary vascular resistance, PPHTN is defined by the presence of elevated pulmonary vascular resistance. Given these seeming...

Full description

Saved in:
Bibliographic Details
Main Authors: Radhika Zopey, Irawan Susanto, Igor Barjaktarevic, Tisha Wang
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Pulmonology
Online Access:http://dx.doi.org/10.1155/2013/561870
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552195704225792
author Radhika Zopey
Irawan Susanto
Igor Barjaktarevic
Tisha Wang
author_facet Radhika Zopey
Irawan Susanto
Igor Barjaktarevic
Tisha Wang
author_sort Radhika Zopey
collection DOAJ
description Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary vascular complications of liver disease. While HPS is characterized by low pulmonary vascular resistance, PPHTN is defined by the presence of elevated pulmonary vascular resistance. Given these seemingly opposing pathophysiologic mechanisms, these conditions were traditionally felt to be mutually exclusive. In this series, we present three patients with severe hepatopulmonary syndrome who had spontaneous resolution of their HPS with the subsequent development of PPHTN. To our knowledge, this is the largest case series presented of this phenomenon in nontransplanted patients. One proposed mechanism for the occurrence of this phenomenon involves dysregulation of the same vascular signaling pathway, which may lead to both pulmonary vascular dilatations and pulmonary arterial remodeling in the same patient. Another theory involves the possible differential binding of endothelin-1, a vasoactive signaling peptide that induces vasoconstriction when bound to receptor A and vasodilation when bound to receptor B. Although the mechanisms for this phenomenon remain unclear, it is important to be vigilant of this phenomenon as it may change the patient's overall treatment plan, especially in regard to appropriateness and timing of liver transplant.
format Article
id doaj-art-f5c26ad8093a435b99e6d90916ab888f
institution Kabale University
issn 2090-6846
2090-6854
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Pulmonology
spelling doaj-art-f5c26ad8093a435b99e6d90916ab888f2025-02-03T05:59:29ZengWileyCase Reports in Pulmonology2090-68462090-68542013-01-01201310.1155/2013/561870561870Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 PatientsRadhika Zopey0Irawan Susanto1Igor Barjaktarevic2Tisha Wang3Division of Pulmonary and Critical Care Medicine, University of California, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90024, USADivision of Pulmonary and Critical Care Medicine, University of California, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90024, USADivision of Pulmonary and Critical Care Medicine, University of California, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90024, USADivision of Pulmonary and Critical Care Medicine, University of California, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90024, USAHepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary vascular complications of liver disease. While HPS is characterized by low pulmonary vascular resistance, PPHTN is defined by the presence of elevated pulmonary vascular resistance. Given these seemingly opposing pathophysiologic mechanisms, these conditions were traditionally felt to be mutually exclusive. In this series, we present three patients with severe hepatopulmonary syndrome who had spontaneous resolution of their HPS with the subsequent development of PPHTN. To our knowledge, this is the largest case series presented of this phenomenon in nontransplanted patients. One proposed mechanism for the occurrence of this phenomenon involves dysregulation of the same vascular signaling pathway, which may lead to both pulmonary vascular dilatations and pulmonary arterial remodeling in the same patient. Another theory involves the possible differential binding of endothelin-1, a vasoactive signaling peptide that induces vasoconstriction when bound to receptor A and vasodilation when bound to receptor B. Although the mechanisms for this phenomenon remain unclear, it is important to be vigilant of this phenomenon as it may change the patient's overall treatment plan, especially in regard to appropriateness and timing of liver transplant.http://dx.doi.org/10.1155/2013/561870
spellingShingle Radhika Zopey
Irawan Susanto
Igor Barjaktarevic
Tisha Wang
Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
Case Reports in Pulmonology
title Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
title_full Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
title_fullStr Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
title_full_unstemmed Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
title_short Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
title_sort transition from hepatopulmonary syndrome to portopulmonary hypertension a case series of 3 patients
url http://dx.doi.org/10.1155/2013/561870
work_keys_str_mv AT radhikazopey transitionfromhepatopulmonarysyndrometoportopulmonaryhypertensionacaseseriesof3patients
AT irawansusanto transitionfromhepatopulmonarysyndrometoportopulmonaryhypertensionacaseseriesof3patients
AT igorbarjaktarevic transitionfromhepatopulmonarysyndrometoportopulmonaryhypertensionacaseseriesof3patients
AT tishawang transitionfromhepatopulmonarysyndrometoportopulmonaryhypertensionacaseseriesof3patients